These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors. Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300 [TBL] [Abstract][Full Text] [Related]
24. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE; Kim MA; Lee HS; Lee BL; Kim WH J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [TBL] [Abstract][Full Text] [Related]
25. [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs]. Shiba K; Matsumoto T; Hirota S Gan To Kagaku Ryoho; 2009 Jul; 36(7):1080-5. PubMed ID: 19620796 [TBL] [Abstract][Full Text] [Related]
27. Imatinib mesylate-induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors. Han H; Yu YY; Wang YH J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S80-3. PubMed ID: 19119132 [TBL] [Abstract][Full Text] [Related]
28. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis. Al-Moundhri MS; Al-Thahli K; Al-Kindy S; Salam J; Rao L Saudi Med J; 2006 Oct; 27(10):1585-7. PubMed ID: 17013488 [TBL] [Abstract][Full Text] [Related]
29. A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. Ryu MH; Kang WK; Bang YJ; Lee KH; Shin DB; Ryoo BY; Roh JK; Kang JH; Lee H; Kim TW; Chang HM; Park JO; Park YS; Kim TY; Kim MK; Lee WK; Kang HJ; Kang YK Oncology; 2009; 76(5):326-32. PubMed ID: 19307738 [TBL] [Abstract][Full Text] [Related]
30. [Targeted therapies in soft-tissue and visceral sarcomas]. Emile JF Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262 [No Abstract] [Full Text] [Related]
31. Aggressive gastrointestinal stromal tumour of the oesophagus with homozygous KIT exon 11 deletion mutation. Cho J; Kang GH; Kim KM; Park J; Shim YM Pathology; 2012 Apr; 44(3):260-1. PubMed ID: 22437744 [No Abstract] [Full Text] [Related]
32. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST). Ali S; Ali S Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849 [TBL] [Abstract][Full Text] [Related]
33. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Ménard C; Blay JY; Borg C; Michiels S; Ghiringhelli F; Robert C; Nonn C; Chaput N; Taïeb J; Delahaye NF; Flament C; Emile JF; Le Cesne A; Zitvogel L Cancer Res; 2009 Apr; 69(8):3563-9. PubMed ID: 19351841 [TBL] [Abstract][Full Text] [Related]
34. Diplopia as a presenting symptom in a gastric gastrointestinal stromal tumor. Baeg MK; Bae SH; Lee KH; Kim J; Park IS; Jin JY Jpn J Clin Oncol; 2011 Feb; 41(2):265-8. PubMed ID: 20930018 [TBL] [Abstract][Full Text] [Related]
35. High efficacy of panobinostat towards human gastrointestinal stromal tumors in a xenograft mouse model. Floris G; Debiec-Rychter M; Sciot R; Stefan C; Fieuws S; Machiels K; Atadja P; Wozniak A; Faa G; Schöffski P Clin Cancer Res; 2009 Jun; 15(12):4066-76. PubMed ID: 19509176 [TBL] [Abstract][Full Text] [Related]
36. Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor. Battistella M; Frémont G; Vignon-Pennamen MD; Gornet JM; Dubertret L; Viguier M Arch Dermatol; 2008 Oct; 144(10):1400-2. PubMed ID: 18936416 [No Abstract] [Full Text] [Related]
37. Soft-tissue sarcomas in adults. Clark MA; Fisher C; Judson I; Thomas JM N Engl J Med; 2005 Aug; 353(7):701-11. PubMed ID: 16107623 [No Abstract] [Full Text] [Related]
38. A phenomenal response to treatment by an advanced tumour. Rahman SH; Roy A; Leahy M; Guillou PJ; Toogood GJ Gut; 2004 Nov; 53(11):1582, 1616. PubMed ID: 15479675 [No Abstract] [Full Text] [Related]
39. Gastrointestinal Stromal Tumors (GIST) special issue. Preface. Patel SR Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S1. PubMed ID: 21116629 [No Abstract] [Full Text] [Related]
40. Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors. Romeo S; Debiec-Rychter M; Van Glabbeke M; Van Paassen H; Comite P; Van Eijk R; Oosting J; Verweij J; Terrier P; Schneider U; Sciot R; Blay JY; Hogendoorn PC; Clin Cancer Res; 2009 Jun; 15(12):4191-8. PubMed ID: 19509155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]